2009Unpublished venueRequires access

Diagnostic value of multi-tumor markers protein biochip detection system in breast cancer

Xiaojun Li

Open publisher page 0 citations

Abstract

Objective:To study the diagnostic value of 12 kinds of tumor markers in protein biochip detection system (C12 detection system for short). Methods: C12 was used to quantitatively detect 12 kinds of tumor markers (CEA,AFP,CA125,CA19-9,NSE,CA242,HCG,HGH,CA15-3,F-PSA,PSA,Ferritin) in the sera of 200 patients with primary breast cancer and 100 healthy women. Results: Of the 22 early-staged breast cancer patients,106 (53%) presented positive tumor marker.Of the 100 healthy women,positive tumor marker was detected in 12 (12%),demonstrating that the sensitivity and specificity for diagnosis of breast cancer were 53% and 88%,respectively,with tumor marker protein biochip. Conclusion: To early breast cancer,the diagnostic value of multi-tumor markers protein biochip detection system (C12 detection system) is limited,it can only be used to enhance the efficiency and accuracy of the tumor detection in clinic.

About this research paper

What this paper is about

Objective:To study the diagnostic value of 12 kinds of tumor markers in protein biochip detection system (C12 detection system for short). Methods: C12 was used to quantitatively detect 12 kinds of tumor markers (CEA,AFP,CA125,CA19-9,NSE,CA242,HCG,HGH,CA15-3,F-PSA,PSA,Ferritin) in the sera of 200 patients with primary breast cancer and 100 healthy women. Results: Of the 22 early-staged breast cancer patients,106 (53%) presented positive tumor marker.Of the 100 healthy women,positive tumor marker was detected in 12 (12%),demonstrating that the sensitivity and specificity for diagnosis of breast cancer were 53% and 88%,respectively,with tumor marker protein biochip. Conclusion: To early breast cancer,the diagnostic value of multi-tumor markers protein biochip detection system (C12 detection system) is limited,it can only be used to enhance the efficiency and accuracy of the tumor detection in clinic.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the diagnostic value of 12 kinds of tumor markers in protein biochip detection system (C12 detection system for short). Methods: C12 was used to quantitatively detect 12 kinds of tumor markers (CEA,AFP,CA125,CA19-9,NSE,CA242,HCG,HGH,CA15-3,F-PSA,PSA,Ferritin) in the sera of 200 patients with primary breast cancer and 100 healthy women. Results: Of the 22 early-staged breast cancer patients,106 (53%) presented positive tumor marker.Of the 100 healthy women,positive tumor marker was detected in 12 (12%),demonstrating that the sensitivity and specificity for diagnosis of breast cancer were 53% and 88%,respectively,with tumor marker protein biochip. Conclusion: To early breast cancer,the diagnostic value of multi-tumor markers protein biochip detection system (C12 detection system) is limited,it can only be used to enhance the efficiency and accuracy of the tumor detection in clinic.

Key concepts: Tumor marker, Biochip, Breast cancer, CA15-3, Medicine, CA 15-3, Protein chip, Ferritin

Related papers

Back to paper searchBrowse research topicsOriginal source
Diagnostic value of multi-tumor markers protein biochip detection system in breast cancer — Research Paper | ScholarLens